Levalbuterol Dosage
Medically reviewed by Drugs.com. Last updated on Aug 11, 2023.
Applies to the following strengths: 0.31 mg/3 mL; 0.63 mg/3 mL; 1.25 mg/0.5 mL; 1.25 mg/3 mL; 45 mcg/inh
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Chronic Obstructive Pulmonary Disease
Inhalation Aerosol:
- 2 inhalations (90 mcg) orally every 4 to 6 hours or
- 1 inhalation (45 mcg) orally every 4 hours
Inhalation Solution:
- Initial dose: 0.63 mg inhaled orally by nebulization three times a day (every 6 to 8 hours)
- For severe asthma, or if not responding to initial dose: 1.25 mg inhaled orally, by nebulization, three times a day
Comments:
- If higher doses of the inhalation solution are used, monitor closely for adverse systemic effects; evaluate risk and benefit of this dose.
- If a previously effective dosage fails to provide the usual response, it may be a sign of destabilization of asthma; reevaluate the patient and treatment and consider the use of corticosteroids.
- The safety and efficacy of the inhalation solution has not been evaluated when mixed together with other drugs in a nebulizer.
Uses: Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease; asthma
Usual Adult Dose for Asthma
Inhalation Aerosol:
- 2 inhalations (90 mcg) orally every 4 to 6 hours or
- 1 inhalation (45 mcg) orally every 4 hours
Inhalation Solution:
- Initial dose: 0.63 mg inhaled orally by nebulization three times a day (every 6 to 8 hours)
- For severe asthma, or if not responding to initial dose: 1.25 mg inhaled orally, by nebulization, three times a day
Comments:
- If higher doses of the inhalation solution are used, monitor closely for adverse systemic effects; evaluate risk and benefit of this dose.
- If a previously effective dosage fails to provide the usual response, it may be a sign of destabilization of asthma; reevaluate the patient and treatment and consider the use of corticosteroids.
- The safety and efficacy of the inhalation solution has not been evaluated when mixed together with other drugs in a nebulizer.
Uses: Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease; asthma
Usual Pediatric Dose for Chronic Obstructive Pulmonary Disease
Inhalation Aerosol:
Less than 4 years: Not approved
4 years or older:
- 2 inhalations (90 mcg) orally every 4 to 6 hours or
- 1 inhalation (45 mcg) orally every 4 hours
Inhalation Solution:
Less than 6 years old: Not approved
6 to 11 years:
- Recommended dose: 0.31 mg inhaled orally by nebulization three times a day
- Maximum dose: 0.63 mg inhaled orally three times a day
- Initial dose: 0.63 mg inhaled orally by nebulization three times a day (every 6 to 8 hours)
- For severe asthma, or if not responding to initial dose: 1.25 mg inhaled orally, by nebulization, three times a day
Comments:
- If higher doses of the inhalation solution are used, monitor closely for adverse systemic effects; evaluate risk and benefit of this dose.
- If a previously effective dosage fails to provide the usual response, it may be a sign of destabilization of asthma; reevaluate the patient and treatment and consider the use of corticosteroids.
- The safety and efficacy of the inhalation solution has not been evaluated when mixed together with other drugs in a nebulizer.
- Recommended dose should not be exceeded.
Uses: Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease; asthma
Usual Pediatric Dose for Asthma
Inhalation Aerosol:
Less than 4 years: Not approved
4 years or older:
- 2 inhalations (90 mcg) orally every 4 to 6 hours or
- 1 inhalation (45 mcg) orally every 4 hours
Inhalation Solution:
Less than 6 years old: Not approved
6 to 11 years:
- Recommended dose: 0.31 mg inhaled orally by nebulization three times a day
- Maximum dose: 0.63 mg inhaled orally three times a day
- Initial dose: 0.63 mg inhaled orally by nebulization three times a day (every 6 to 8 hours)
- For severe asthma, or if not responding to initial dose: 1.25 mg inhaled orally, by nebulization, three times a day
Comments:
- If higher doses of the inhalation solution are used, monitor closely for adverse systemic effects; evaluate risk and benefit of this dose.
- If a previously effective dosage fails to provide the usual response, it may be a sign of destabilization of asthma; reevaluate the patient and treatment and consider the use of corticosteroids.
- The safety and efficacy of the inhalation solution has not been evaluated when mixed together with other drugs in a nebulizer.
- Recommended dose should not be exceeded.
Uses: Treatment or prevention of bronchospasm in patients with reversible obstructive airway disease; asthma
Renal Dose Adjustments
Use with caution.
Liver Dose Adjustments
Data not available
Dose Adjustments
- If clinically warranted due to insufficient bronchodilator response, the dose of the inhalation solution may be increased in elderly patients as tolerated, in conjunction with frequent clinical and laboratory monitoring, to the maximum recommended adult daily dose.
Precautions
Inhalation Aerosol: Safety and efficacy have not been established in patients younger than 4 years.
Inhalation Solution: Safety and efficacy have not been established in patients younger than 6 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- This drug is for oral inhalation only.
- Administer by nebulization using a standard jet nebulizer (with a face mask or mouthpiece) connected to an air compressor.
- The safety and efficacy of the inhalation solution have been established only when administered using the PARI LC Jet and PARI LC Plus nebulizers, and the PARI Master Dura-Neb 2000 and Dura-Neb 3000 compressors.
- Avoid spraying in the eyes.
- Prime the inhaler before using for the first time and when it has not been used for more than 3 days by releasing 4 test sprays into the air, away from the face.
- Wash the actuator with warm water and air dry thoroughly at least once a week.
General: This drug is not a substitute for corticosteroids and may not be adequate to control asthma; consider adding a corticosteroid to the treatment with this drug.
Monitoring:
- Signs and symptoms of adverse systemic effects
- Metabolic: Potassium levels
Patient advice:
- Discontinue immediately if hypersensitivity reactions and/or paradoxical bronchospasm occur.
- Excessive use may be fatal; recommended dose should not be exceeded.
More about levalbuterol
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (33)
- Side effects
- During pregnancy
- Drug class: adrenergic bronchodilators
- Breastfeeding
- En español
Patient resources
- Levalbuterol inhalation drug information
- Levalbuterol (Advanced Reading)
- Levalbuterol Inhalation Solution
Other brands
Xopenex, Xopenex HFA, Xopenex Concentrate
Professional resources
- Levalbuterol prescribing information
- Levalbuterol HFA Aerosol (FDA)
- Levalbuterol Inhalation Solution Concentrate (FDA)
Other brands
Xopenex, Xopenex HFA, Xopenex Concentrate
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.